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Abstract 
The avid hybridization of peptide nucleic acid (PNA) to DNA and RNA along with the 
molecule’s biological stability has led it to be used in both antisense and antigene capacities. 
PNA acts against translation via a steric blockade mechanism. It is therefore reasonable to 
assume that increased heteroduplex stability could lead to increased potency. Two ways of 
doing this were explored. I) N-Terminal attachment of a platinous chloride chelating moiety 
to PNA complementary to Xenopus noggin was synthesized with the objective of selective, 
covalent platination of the target transcript in vivo. Phenotypes consistent with knockdown of 
the selected gene product were observed; however, it remains unclear whether this is solely 
due to site-specific platination. II) The use of the modified cytosine nucleobase [bis-o-
(aminoethoxy)phenyl]pyrrolocytosine (boPhpC) was previously shown to increase 
heteroduplex stability, putatively by interaction with guanine at both the Watson-Crick and 
Hoogsteen faces. PNAs containing this base were synthesized to target mutant huntingtin 
mRNA - of which the product is the causative agent of Huntington’s disease – and tested in 
patient derived fibroblasts where selective inhibition of mutant huntintin was observed with 
concomitant fluorescence imaging. 
Modified nucleobases find use in fields ranging from materials science to cytogenetics and 
has been an area of much endeavour over the past years. Modifications at the 5-position of 
uracil abound but examples of similarly modified cytosine are lacking. Rapidly developing 
the inventory of cytosine analogues is a primary goal of ours. We aim to synthesize 
compounds that may be used as base discriminating fluorophores, created pre- or post-
synthetically. Through the reaction of 5-ethynyldeoxycytidine with 1,3-dipoles such as  
nitrile oxides or azides a series of heterocycle-appended cytosine analogues have been 
prepared and their fluorescence properties studied. They exhibit moderate to good quantum 
yields with high sensitivity to their environment and are considered good candidates for 
further use as base-discriminating fluorophores. Based on the known pyrrolocytosine 
scaffold, Indole-3-acetamide substituted deoxypyrrolocytidine (IAMpC) has shown the 
highest degree of solvatochromism for any pyrrolocytosine analogue known to date. The 
synthesis of oligodeoxynucleotides containing this base was carried out; however, final 
deprotection of the base does not proceed smoothly and the modification was found to be 
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slightly destabilizing towards duplex formation.   
Keywords 
DNA, PNA, mRNA, Platinum (II), Cisplatin, PAGE, Base-discriminating Fluorophore, 
Copper-catalyzed Azide/Alkyne Cycloaddition, Antisense, Huntington’s Disease, Nucleoside 
Analogue, Hydrogelator.   
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Preface 
During my undergraduate degree, the sequence of the human genome, consisting of 
approximately three billion base pairs, was published simultaneously by two groups. This 
occasion fell close to the 50th anniversary of Watson and Crick’s discovery of the double 
helix. Now, as I come to the end of my Ph.D., we celebrate the 50th anniversary of the 
beginning of the determination of the genetic code. In approximately a decade the world 
went from not knowing the structure of DNA to knowing the gist of the language it spoke. 
The astounding pace of DNA related research continues unabated. DNA is the most 
fundamental of biological macromolecules and consequently, the most fascinating. Because 
of this, DNA attracts biologists, physicists, and chemists alike. However, chemists are 
perhaps the luckiest of these three categories of people: we can grasp the biology with some 
determined reading and (although I personally don’t care to do so) many of us can approach 
the physics. Moreover, it is only chemists that can see the true beauty and evolutionary 
genius of the molecule in its organic chemistry. It is also only us that can rationally modify 
the molecule to make it do weirder and more wonderful things. We can change the base, the 
phosphate, or the sugar; tagging almost whatever we want to it, mixing it up with different 
monomers, activating it with light, forming scaffolds and, make it glow. I count myself lucky 
to have been introduced to nucleic acids, and having met them, I forsee spending the rest of 
my life in their intimate company.  
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Chapter 1  
1 Introduction to selected aspects of nucleic acid 
chemistry 
Over half a century since the elucidation of DNA’s molecular architecture and a decade 
since the completion of the human genome project, nucleic acids still hold many 
questions.  The deliberate application of synthetic organic chemistries towards 
nucleosides, DNA and their analogues has a rich history. The development of high-
yielding oligomerization chemistries opened many doors for the study of nucleobase and 
backbone modifications, of which there is a seemingly endless array. These modifications 
can skew the basic properties of DNA to tune hybridization efficiency, enzymatic 
stability/biological recognition and photophysical properties. In this chapter selected 
historical and recent literature on the chemical aspects of nucleic acids and peptides will 
be discussed in order to put the reader ‘in frame’ for the present work. Excerpts of this 
chapter have been taken from Dodd, D.W.; Hudson, R.H.E. Mini-Rev. Org. Chem., 2009, 
6, 378-391.  
1.1 Intrinsically fluorescent base discriminating nucleoside 
analogues  
Modified nucleosides possessing intrinsically fluorescent heterocycles as base surrogates 
that are capable of canonical base-pairing are becoming important biomolecular tools. 
These “base-discriminating fluorophores” (BDFs) find use in hybridization-based 
mismatch detection, elucidation of DNA damage and the study of localized structural 
phenomena as exemplified in the study of ribozymes and nucleic acid/ligand interactions.  
Classically, the central dogma of biology purports that the characteristics which make us 
unique are peculiar to the heritable material within almost every cell of our body: our 
DNA. It is therefore of no surprise that many disease states, both acquired and heritable, 
are derived from permutations within the genome. Mutations can make one more 
susceptible to heart disease, various carcinoma and are also the cause of diseases such as 
phenylketonurea, autism and cystic fibrosis, to name only a few. Diagnosis of mutations 
2 
 
that make one, or one’s progeny, susceptible to disease is a very desirable advancement 
of modern medicine and many research groups are currently working on making this 
process more rapid and economical. A few existing techniques for sequence analysis are 
outlined in the following paragraphs.  
One of the most frequently used methods for the detection of permutations within a 
polynucleotide sequence employs molecular beacons based on fluorescent resonant 
energy transfer (FRET).1 The quintessential morphology of a molecular beacon consists 
of an oligonucleotide labeled at opposing termini with a fluorophore and a quenching 
moiety. Complementary sequences are placed at each terminus such that a hairpin 
structure is formed and the loop region is chosen to be complementary to the target 
oligonucleotide sequence to be analyzed. Upon hybridization of the interrogated 
sequence to the loop region, the stem opens and the fluorophore is no longer quenched as 
this quenching is distance dependent (Fig. 1-1). This basic technique can be applied in a 
variety of different ways, the fluorophore and quencher may be appended to different 
sequences and FRET can be used to obtain emission at differing wavelengths.2  
 
Figure 1-1: Illustration of the underlying mechanism of molecular beacon operation 
based on FRET.  
Detection of single nucleotide polymorphisms (SNPs) can oftentimes be difficult due to 
the sheer size of the genome. A point mutation may occur only in low abundance creating 
the problem of interference from the wild-type gene. In order to increase sensitivity, 
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sequences can be examined and amplified through PCR-clamping using oligonucleotide 
analogues that will suppress the association of a primer to the template by steric 
hindrance.  PCR clamping is most often peptide nucleic acid (PNA) mediated. Due to the 
unnatural N-(2-aminoethyl)glycine derived backbone, PNA is not recognized 
enzymatically and therefore does not act as a primer for DNA polymerase.3 When a 
sequence of PNA is complementary to a PCR primer site it will virtually eliminate the 
formation of PCR product. PNA can be used in this manner to selectively silence or 
amplify genes differing by only one base. This technique, in conjunction with 
hybridization probes, has been used by several groups to great effect. The detection of 
point mutations using a wild-type-specific PNA and a mutant-specific PCR primer has 
been carried out for oncogenes4,5 and even on mitochondrial DNA.6 
Full sequencing of a PCR amplified gene is the archetypal method of SNP analysis; this 
technique is currently undesirable as it is costly and time consuming despite the 
significant advances that continue to be made in this area.  
Electrochemical means may also be used for SNP detection. Many different approaches 
have been used, although most involve oligonucleotide modified electrodes that result in 
differing charge transfer rates upon complementary sequence binding. As an example of 
this, a recent paper has illustrated that a mismatch can be discriminated through labeling 
of an oligonucleotide immobilized on a gold surface with anthraquinone at the 2’- 
position, as the anthraquinone moiety intercalates the charge transfer rate decreases 
allowing for mismatch detection.7 Electrochemical mismatch detection offers the 
advantages of simple readout and amenability to digitization. Microarray analysis of 
SNPs by electrochemical means remains limited as a mechanical connection is required 
to each electrode pad. This would make the manufacture of larger arrays, required for full 
sequence-screening, a difficult challenge.8    
The aforementioned techniques, molecular beacons in particular, are limited as they rely 
in differences in hybridization efficiency. These differences vary greatly with sequence 
context and with the ionic strength of the medium and strict hybridization conditions 
must be met.9 In the context of oligonucleotide arrays, variations in packing density can 
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affect hybridization efficiency therefore making the manufacture of high-throughput 
screening devices technically challenging.10 
Fluorescent base-pairing nucleoside analogues which may fluorometrically respond to 
hybridization when placed within an oligonucleotide sequence are of high interest as they 
overcome the reliance on hybridization efficiency and offer a conveniently measured 
parameter in the wavelength or intensity of light emission (Fig. 1-2). These base-
discriminating fluorophores (BDFs) may be used for a wide range of sensing applications 
including the detection of SNPs which may be used for the diagnosis of heritable diseases 
in a less costly and more expedient manner than full sequencing. 
 
 
Figure 1-2: Illustration of the principle of sequence readout by a base discriminating 
fluorophore (BDF) containing probe. The interaction of a BDF-containing probe 
with a complementary sequence leads to an observable property. 
The use of BDFs allows for the elucidation of localized events as opposed to other 
methodologies which monitor global structural phenomena (UV-Vis, CD spectroscopy). 
Other methods for detecting localized structural events do exist, such as NMR 
spectroscopy and gel electrophoresis of kinetically trapped radiolabeled products; 
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however, these techniques are time consuming and limited with respect to reaction time 
scale.   
As the natural nucleobases are essentially non-emissive,11 much work has been put 
towards the synthesis of base analogues which are luminescent. In the design of novel 
base-discriminating fluorophores several basic criteria should be met. The fluorophores 
should maintain a high degree of structural similarity with the natural nucleobases so as 
not to affect the hybridization efficiency, the compounds must obviously be fluorescent, 
their excitation wavelengths should not be within the absorption range of biological 
macromolecules, and the fluorescence should be sensitive to microenvironmental 
conditions. The fluorescence response may be a change in emission wavelength, an 
increase or decrease in quantum efficiency or length of the excited state lifetime; 
however, dramatic changes in emission wavelength or intensity are the most conveniently 
measured parameters. 
Figure 1-3: Representative molecules of the different classes of BDF as defined by 
Tor.12 
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Tor has divided fluorescent base analogues into five basic categories: isomorphic base 
analogues, pteridines as purine analogues, extended nucleobases, conjugated base 
analogues, and aromatic hydrocarbon and chromophoric base analogues (Fig. 1-3).12 
Fluorescent base analogues may be more selectively divided into two categories which 
are capable of canonical base pairing: those possessing pendant fluorophores and 
intrinsically fluorescent nucleoside analogues. Below are pictured representative 
molecules of these classes (Fig. 1-4).13,14 Both of these molecules are able to hydrogen 
bond with natural bases and respond fluorometrically to hybridization. The former class 
often has an advantage in that higher overall brightness (brightness is defined by the 
quantum yield multiplied by the extinction coefficient at the excitation maximum) and 
greater quantum yields are often achieved through the attachment of a traditional 
chromophore.  However, fluorescence spectroscopy is a fantastically sensitive technique 
and oftentimes highly luminescent molecules are not required to be a practical and useful 
reporter group.  
The use of conventional fluorescent moieties, attached to the base via a flexible 
linker, can allow independent movement of the fluorophore, this can make 
interpretation of results complicated as the fluorescence response is not necessarily 
originating from the area of interest. The intrinsically fluorescent BDF category has 
become attractive as it is the nucleobase itself whose environment is being monitored, 
they are synthetically accessible and also have potential for biological incorporation. 
Such intrinsically fluorescent, complementary base-discriminating/pairing nucleobase 
Figure 1-4: Representative molecules of the two basic fluorescent nucleobase 
analogue designs: those containing a pendant fluorophore, and the intrinsically 
fluorescent 6-phenylpyrrolocytosine.13,14 
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analogues are the subject of this sub-chapter.  Whenever possible the photophysical 
parameters characterizing the BDFs ablility to act as a reporter group are given; 
however, for some analogues this information is not yet available. 
Intrinsically Fluorescent Purine Nucleobase Analogues:  Complementarity and 
Response to Pyrimidines 
Isomorphic bases:  2-aminopurine and 8-azaguanine 
The base analogues 2-aminopurine (2-AP) and 8-azaguanine (8-azaG) are historically 
two of the most often used isomorphic, fluorescent nucleobases.  Their overall size 
matches that of the natural bases and they are able to form isostructural Watson-Crick 
base pairs (Fig. 1-5). 2-AP, a constitutional isomer of adenine, has been used for almost 
40 years.15 Owing to its high quantum yield as the free nucleoside in aqueous solution (Φ 
= 0.68) and extreme sensitivity to microenvironmental changes with drastically lower 
emission observed in single-stranded (ss) and double stranded (ds) oligonucleotides (as 
much as 100 fold decrease in emission in dsDNA),16 2-AP has been employed in many 
studies of nucleic acid structure and dynamics and in a wide array of biochemical assays. 
Examples include: real-time monitoring of hammerhead ribozyme folding, 
oligonucleotide cleavage and inhibition and nucleic acid/protein and nucleic acid/drug 
interactions.17 2-AP can form Watson-Crick type base pairs with thymine, uracil or 
cytosine, this can either be a benefit or a drawback, depending on the application. It also 
has a red shifted absorption spectrum which allows differential excitation in the presence 
of biological macromolecules. 
8-azaG is another isomorphic purine analogue which can be enzymatically incorporated 
into oligonucleotides.  It is relatively emissive, exhibits a high degree of 
solvatofluorochromism and is quenched by adjacent nucleobases (Fig. 1-5). 8-
azaguan(os)ine has a high quantum yield when N1 is deprotonated at high pH (Φ = 0.55) 
but much lower fluorescence when the natural Watson-Crick base-pairing face is 
presented. One of the more interesting and recent advances made with this BDF has been 
the development of a highly efficient enzymatic synthesis of the triphosphate from 8-
azaguanine and the establishment of pH dependent fluorescence within a structured 
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oligoribonucleotide (with implications towards ribozyme mechanism elucidation).18      
Purines modified at the 8-position 
The 8-position of purines lends itself well to derivatization; 8-bromoadenosine is 
remarkably easy to prepare in high yield and can be used in a variety of transition metal-
catalyzed cross-couplings. Deoxyadenosine and guanine derivatives with phenol directly 
attached at the 8-position can be accessed through the coupling of hydroxyphenylboronic 
acid with the appropriate 8-bromonucleoside in the palladium catalyzed Suzuki-Miyaura 
reaction.19 These compounds are of interest for several reasons: the compounds are 
biomarkers for phenol exposure and are therefore of use for the study of mechanisms of 
carcinogenicity, the compounds exhibit pH dependent fluorescence 20 and the phenolate, 
anionic form of the modified base can act as a quencher through photoinduced electron 
transfer (PET).21  Although these nucleosides have not yet been incorporated into 
oligonucleotides, their high quantum yields at neutral pH (Φ =  0.25–0.56) could make 
them quite useful as BDFs. 
Various other moieties have been attached to purines in the same manner including 
Figure 1-6: Purine nucleosides derivatized at C-8 (R = H, bpy). 
Figure 1-5: The isosteric base analogues 2-aminopurine and 8-azaguanine in 
hybridization with their natural base complements uracil and cytosine, 
respectively. 
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bipyridine and phenanthroline for use as metal chelators (demonstrated for RuII) and 
various aryl substituents to tune fluorescence properties (Fig. 6).22 
Triazolyl adenosines have been made and characterized through a collaborative effort and 
have been found to be highly fluorescent (Fig. 1-7 left). The first report by Dyrager et al. 
showed that quantum yields as high as 0.62 are achieved.23 A follow up study also 
showed that the base (when incorporated into oligomers) was sensitive to its 
microenvironment, caused only mild structural perturbations to B-form DNA and formed 
base pairs with thymine and also, more surprisingly, adenine.24 The high fluorescence 
observed was surprising to us as we had synthesized geometric isomers of the compounds 
reported (Fig. 1-7, right) and found quantum yields to be very low (ΦF ~ 0.02) 
(unpublished results).  
Figure 1-7: Geometric isomers of 8-triazolyldeoxyadenosines for use as BDFs, 
R=Alkyl. 
Both syntheses started from 8-bromoadenosine, the former work then used a 
Sonogoashira coupling to introduce the alkyne while we took the opposite approach of 
introducing an azide via a simple SNAr with sodium azide. We found that 8-
azidoadenosine was very unreactive towards cycloaddition with alkynes and were only 
able to produce two compounds in low yield (R = Ph, R = EtOMe). 
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Purines modified at the 6-position:  2-Amino-6-(2-thienyl)purine and 2-amino-6-(2-
thiazolyl)purine 
The compounds shown in figure 1-8 have been known for some time and applications for 
the highly emissive base analogues continue to be found.25-27 The unnatural base pairs of 
2-amino-6-(2-thienyl)purine with 2-oxopyridine and 2-amino-6-(2-thiazolyl)purine with 
imidazolin-2-one remarkably function in transcription with good fidelity and hence may 
be placed specifically within an RNA transcript with ease. Both the thienyl and 
thiazolylpurines have quantum yields from 0.41-0.46 as the free 5’-monophosphates. 
These quantum yields are roughly halved upon incorporation into a ss oligonucleotide 
and halved again when in ds DNA/RNA. Used alone or in FRET experiments, with 
fluorescein derivatives (FAM) as an acceptor moiety, accurate descriptions of 
hybridization events have been obtained. When placed adjacent to one another, the 
modified bases exhibit self-quenching behaviour but may still allow for the excitation of 
a nearby FAM moiety. The authors suggest that this may be desirable as it would enable 
the use of excess probe to test sequence in biological assays.27    
 
Pteridine nucleoside analogues  
Pteridines are naturally occurring compounds, originally isolated from the wings of pierid 
butterflies by the pioneering biochemist F.G. Hopkins in 1895.28 Hopkins would later 
receive a Nobel prize for his discovery of vitamins (not that this is of any particular 
Figure 1-8: 2-amino-6-(2-thienyl)purine and 2-amino-6-(2-thiazolyl)purine used as 
guanosine mimics despite not presenting an isostructural Watson-Crick face. 
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relevance to us here). Pteridine derivatives have had many pharmaceutical applications, 
particularly as anti-cancer drugs. Pteridines have more recently been utilized as 
nucleoside analogues; they are highly fluorescent and are synthetically accessible through 
the condensation of the appropriate triaminopyrimidine with the desired pyruvate 
derivative (Fig. 1-9).29  
Once the base analogue has been synthesized, N-glycosylation can be carried out to yield 
the desired nucleoside, this in turn can be converted to the corresponding 
phosphoramidite by well established methods.  
The pteridines described by the Hawkins group are structurally similar to the natural 
purine bases, containing the appropriate hydrogen bond donor and acceptor components, 
with one exception (vide infra). The compounds 3-methylisoxanthopterin (3MI) and 6-
methylisoxanthopterin (6MI) have been employed as guanosine analogues while 4-
amino-6-methyl-8-(2’-deoxyribofuranosyl)-7(8H)-pteridone (6MAP) and 4-amino-2,6-
dimethyl-(2’-deoxyribofuranosyl)-7(8H)-pteridone (with the unforntunate acronym 
DMAP) have been used as adenosine mimics.30 While other derivatives have been 
synthesized, it is the aforementioned compounds that have found the greatest success in 
the elucidation of DNA structural events.  
The applications of the pteridines as BDFs are diverse as the compounds are highly 
fluorescent (Φ = 0.77-0.88 for the adenosine analogues and 0.39-0.48 for the guanosine) 
and highly sensitive to microenvironmental conditions. All compounds are well tolerated 
within the duplex excepting 3MI due to the methyl group at the 3-position interfering 
with hydrogen bonding. This methylation destabilizes the duplex to a similar extent as 
would a single canonical mismatch. 
Figure 1-9: Pteridine purine analogues. 
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Pteridines have been used in the following applications: HIV-1 integrase activity assays, 
alkyl transferase coupled assays, use as hydridization probes, HU protein binding 
detection, ‘A-tract’ structure detection, RNA polymerase activity and intracellular 
oligonucleotide transport analysis.30 
Intrinscially Fluorescent Pyrimidine Nucleobase Analogues:  Complementarity and 
Response to Purines 
5-Ethynyluridine 
Variously substituted 5-ethynyluridine derivatives have been exploited in our laboratory 
for mismatch detection. These structurally simple and compact fluorophores are able to 
report hybridization events by “turning on” in the presence of a match sequence when 
placed internally within the modified strand. The greatest fluorescence response, out of a 
small selection of compounds, was observed for a p-methoxyphenylethynyluracil 
containing probe (Fig. 1-10) giving a six-fold increase in fluorescence upon encountering 
a match sequence.31  
 
Figure 1-10: 5-(p-methoxyphenylethynyl)uracil  containing oligonucleotide in the 
presence of a match sequence (black) as compared to ss (grey).31 
The mismatch duplexes offer surprising results: when the mismatch is guanine the 
fluorophore is quenched considerably; when it is thymine, the chromophore suffers an 
intermediate degree of quenching and; when it is cytosine, mismatch duplexes are not 
quenched significantly. These data imply that the fluorophores are exquisitely responsive 
to their local environment and may therefore find further use in determining DNA 
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structural characteristics and ligand/DNA interactions.  
Related alkynyluracils have been exploited for mismatch detection by Brown and co-
workers. Again using Sonogashira cross-couplings, anthracenyl-ethynyl (Ae) and 
naphthalenyl-ethynyl (Ne) moieties have been appended to deoxyuridine at the 5-position 
(Fig. 1-11).32,33 The corresponding anthracenyl -diyne (Aee) was also synthesized and 
these compounds were found to be only marginally destabilizing towards duplex 
formation. As is typically the case with fluorophores appended to pyrimidines at the 5-
position, an increase in fluorescence was observed on duplex formation due to a change 
in the polarity of the microenvironment when the chromophore is projected into the 
aquated major groove of dsDNA versus its position in ss form.32,33 
Figure 1-12: Phenyl, naphthalenyl and anthracenyl-alkyne derivatized 
deoxyuridines used for mismatch detection (R = H, OMe).31,33 
Figure 1-11: Anthracenyl-ethynyl (Ae) derivatized riboguanosine  (G) and 
ribocytidine (C) and dimethylaniline-(DMA) modified bases.34 
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Alkynylnaphthalene analogue of deoxthymidine (AeT) containing oligomers showed the 
greatest increase in emission upon binding to a match sequence; however, when 
presented with a C mismatch the fluorescence was also much increased (quantum yields 
not reported). The results were very similar with the anthracene containing oligomer only 
with overall lower fluorescence. The diyne compound gave surprising results, the 
fluorescence increased greatest in the case of a C or T mismatch, the T mismatch increase 
in emission intensity was also accompanied by a bathochromic shift of 12 nm. It can be 
said that all three of the compounds tested could potentially be used to effect in A/G SNP 
typing.33  A similar modification, but for cytidine, was reported earlier by Sessler and 
coworkers.34 They prepared a pair of base-modified ribonucleosides to examine 
photoinduced electron transfer in a hydrogen bonded ensemble.  They chose to prepare a 
C8-modified guanosine and a C5-modified cytidine (Fig. 1-12). 
Although the purpose of the study was not base-discrimination, the fluorescence spectra 
of AeC and AeG were reported.  The fluorescence was mostly characteristic of 
anthracene, yet each modified base had slightly different photophysical properties.  Given 
the conjugated nature of the linkage of the luminophore to the nucleobase, it is reasonable 
to suspect that they may be responsive to base pairing in the context of an 
oligonucleotide.  Likwise, the dimethylaniline-modified bases, especially DMAG, is 
structurally related to modified purines already presented (Fig. 1-6).  A detailed 
characterization of DMAG and DMAC were not reported in this work.  
A fluorene derivatized deoxyuridine35 nucleoside and the analogous PNA monomer 
(Fig.1-13) have both been synthesized and were found to be moderately fluorescent (Φ = 
0.14 for the free nucleoside).36 Oligonucleotides containing the nucleoside analogue were 
amenable to SNP typing, selectively fluorescing in the presence of a match sequence in a 
quencher-free molecular beacon construct.35  
